Polycystic Ovary Syndrome: The Controversy of Diagnosis by Ultrasound

ABSTRACT

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder. The criteria used to establish the diagnosis remain controversial. The 1990 National Institutes of Health conference guidelines required a combination of both chronic anovulation and clinical/or biochemical signs of hyperandrogenism. These criteria were revised in 2003 at the Rotterdam European Society of Human Reproduction and Embryology/American Society of Reproductive Medicine consensus workshop to include ultrasound polycystic ovarian morphology (PCOM) as one of the two of three criteria necessary for establishing the diagnosis of PCOS. The inclusion of PCOM sparked a controversy as it broadens the population of women who meet the criteria for PCOS and allows for the creation of two phenotypically different patient populations who previously would have been excluded. The ultrasound findings, which are consistent with PCOM, include an assessment of follicle number and/or ovarian volume. As technology advances with two-dimensional and three-dimensional ultrasound, our ability to discretely evaluate independent portions of the ovary may help to redefine the criteria of PCOM and thus standardize for clinical and research interests a more specific descriptor for PCOM.

KEYWORDS

PCOS - ultrasound - Rotterdam - ovarian stroma - polycystic ovarian morphology - PCO - PCOM

REFERENCES

• 1 Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population.  J Clin Endocrinol Metab. 2004;  89 2745-2749
• 2 Stein I, Leventhal M. Amenorrhoea associated with bilateral polycystic ovaries.  Am J Obstet Gynecol. 1935;  29 181-185
• 3 Rebar R, Judd H L, Yen S S, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.  J Clin Invest. 1976;  57 1320-1329
• 4 Kalro B N, Loucks T L, Berga S L. Neuromodulation in polycystic ovary syndrome.  Obstet Gynecol Clin North Am. 2001;  28 35-62
• 5 Lobo R A. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.  Clin Obstet Gynaecol. 1985;  12 633-647
• 6 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.  Endocr Rev. 1997;  18 774-800
• 7 Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.  Diabetes. 1989;  38 1165-1174
• 8 Balen A H, Laven J S, Tan S L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions.  Hum Reprod Update. 2003;  9 505-514
• 9 Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.  J Clin Endocrinol Metab. 2005;  90 4650-4658
• 10 Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal.  Fertil Steril. 2005;  83 1343-1346
• 11 Ehrmann D A, Liljenquist D R, Kasza K, Azziz R, Legro R S, Ghazzi M N. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2006;  91 48-53
• 12 The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).  Hum Reprod. 2004;  19 41-47
• 13 Boomsma C M, Eijkemans M J, Hughes E G, Visser G H, Fauser B C, Macklon N S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.  Hum Reprod Update. 2006;  12 673-683
• 14 Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F Polycystic Ovary Syndrome. Boston, MA; Blackwell Scientific 1992: 377-384
• 15 Azziz R. PCOS: a diagnostic challenge.  Reprod Biomed Online. 2004;  8 644-648
• 16 Polson D W, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women.  Lancet. 1988;  1 870-872
• 17 Carmina E, Lobo R A. Do hyperandrogenic women with normal menses have polycystic ovary syndrome?.  Fertil Steril. 1999;  71 319-322
• 18 Swanson M, Sauerbrei E E, Cooperberg P L. Medical implications of ultrasonically detected polycystic ovaries.  J Clin Ultrasound. 1981;  9 219-222
• 19 Adams J, Franks S, Polson D W et al.. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.  Lancet. 1985;  2 1375-1379
• 20 Goldstein S R. Incorporating endovaginal ultrasonography into the overall gynecologic examination.  Am J Obstet Gynecol. 1990;  162 625-632
• 21 Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?.  Hum Reprod. 2003;  18 598-603
• 22 Dewailly D, Catteau-Jonard S, Reyss A C, Maunoury-Lefebvre C, Poncelet E, Pigny P. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.  Hum Reprod. 2007;  22 1562-1566
• 23 Conway G S, Honour J W, Jacobs H S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients.  Clin Endocrinol (Oxf). 1989;  30 459-470
• 24 Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries.  Hum Reprod. 2005;  20 2893-2898
• 25 Erickson G F, Magoffin D A, Dyer C A, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships.  Endocr Rev. 1985;  6 371-399
• 26 Al-Took S, Watkin K, Tulandi T, Tan S L. Ovarian stromal echogenicity in women with clomiphene citrate-sensitive and clomiphene citrate-resistant polycystic ovary syndrome.  Fertil Steril. 1999;  71 952-954
• 27 Buckett W M, Bouzayen R, Watkin K L, Tulandi T, Tan S L. Ovarian stromal echogenicity in women with normal and polycystic ovaries.  Hum Reprod. 1999;  14 618-621
• 28 Fulghesu A M, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.  Fertil Steril. 2001;  76 326-331
• 29 Fulghesu A M, Angioni S, Frau E et al.. Ultrasound in polycystic ovary syndrome-the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.  Hum Reprod. 2007;  22 2501-2508
• 30 Battaglia C, Genazzani A D, Artini P G, Salvatori M, Giulini S, Volpe A. Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome.  Ultrasound Obstet Gynecol. 1998;  12 180-187
• 31 Carmina E, Orio F, Palomba S, Longo R A, Lombardi G, Lobo R A. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.  Fertil Steril. 2005;  84 413-419
• 32 Agrawal R, Sladkevicius P, Engmann L et al.. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.  Hum Reprod. 1998;  13 651-655
• 33 Engmann L, Sladkevicius P, Agrawal R, Bekir J S, Campbell S, Tan S L. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment.  Fertil Steril. 1999;  71 22-29
• 34 Agrawal R, Conway G, Sladkevicius P et al.. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.  Fertil Steril. 1998;  70 651-658
• 35 Raine-Fenning N J, Campbell B K, Clewes J S, Johnson I R. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique.  Ultrasound Med Biol. 2003;  29 1685-1690
• 36 Jarvela I Y, Mason H D, Sladkevicius P et al.. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.  J Assist Reprod Genet. 2002;  19 582-590
• 37 Lam P M, Raine-Fenning N. The role of three-dimensional ultrasonography in polycystic ovary syndrome.  Hum Reprod. 2006;  21 2209-2215
• 38 Allemand M C, Tummon I S, Phy J L, Foong S C, Dumesic D A, Session D R. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound.  Fertil Steril. 2006;  85 214-219
• 39 Faure N, Prat X, Bastide A, Lemay A. Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome.  Hum Reprod. 1989;  4 468-472
• 40 Yoo R Y, Sirlin C B, Gottschalk M, Chang R J. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study.  Fertil Steril. 2005;  84 985-995
• 41 Timor-Tritsch I E, Monteagudo A, Rebarber A, Goldstein S R, Tsymbal T. Transrectal scanning: an alternative when transvaginal scanning is not feasible.  Ultrasound Obstet Gynecol. 2003;  21 473-479
• 42 Azziz R, Carmina E, Dewailly D et al.. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.  J Clin Endocrinol Metab. 2006;  91 4237-4245
• 43 Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.  Clin Endocrinol (Oxf). 2007;  67 735-742
• 44 Kyei-Mensah A A, LinTan S, Zaidi J, Jacobs H S. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome.  Hum Reprod. 1998;  13(6) 1437-1441
• 45 Dolz M, Osborne N G, Blanes J et al.. Polycystic ovarian syndrome: assessment with color Doppler angiography and three-dimensional ultrasonography.  J Ultrasound Med. 1999;  18(4) 303-313
• 46 Jarvela I Y, Mason H D, Sladkevicius P et al.. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.  J Assist Reprod Genet. 2002;  19(12) 582-590
• 47 Pan H A, Wu M H, Cheng Y C, Li C H, Chang F M. Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography.  Hum Reprod. 2002;  17(9) 2484
• 48 Ng E H, Chan C C, Yeung W S, Ho P C. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.  Hum Reprod. 2005;  20(7) 1881-1886
• 49 Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.  J Clin Endocrinol Metab. 2006;  91 781-785